Labcorp (LH) analyst forecast and price target
Analyst forecast
Consensus of 21 analyst ratings
Based on 7 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Piper Sandler | Maintained | Neutral | $309.00 from $300.00 | Aug 4, 2026 |
| JP Morgan | Maintained | Overweight | $360.00 from $330.00 | Aug 3, 2026 |
| Barclays | Maintained | Equal-Weight | $320.00 from $290.00 | Jul 31, 2026 |
| Truist Securities | Maintained | Buy | $350.00 from $320.00 | Jul 31, 2026 |
| Morgan Stanley | Maintained | Overweight | $338.00 from $308.00 | Jul 31, 2026 |
| Baird | Maintained | Outperform | $338.00 from $335.00 | Jul 13, 2026 |
| B of A Securities | Maintained | Buy | $320.00 from $300.00 | Jul 13, 2026 |
| Evercore ISI Group | Maintained | Outperform | $300.00 from $280.00 | Apr 8, 2026 |
| Piper Sandler | Maintained | Neutral | $300.00 from $270.00 | Feb 24, 2026 |
| Baird | Maintained | Outperform | $326.00 from $313.00 | Feb 18, 2026 |
| JP Morgan | Maintained | Overweight | $330.00 from $319.00 | Feb 18, 2026 |
| JP Morgan | Maintained | Overweight | $319.00 from $317.00 | Feb 6, 2026 |
| JP Morgan | Maintained | Overweight | $317.00 from $291.00 | Nov 7, 2025 |
| UBS | Maintained | Buy | $320.00 from $325.00 | Oct 29, 2025 |
| Mizuho | Maintained | Outperform | $320.00 from $285.00 | Oct 17, 2025 |
| UBS | Maintained | Buy | $325.00 from $305.00 | Oct 17, 2025 |
| Evercore ISI Group | Maintained | Outperform | $305.00 from $300.00 | Oct 3, 2025 |
| Barclays | Maintained | Equal-Weight | $290.00 from $275.00 | Oct 2, 2025 |
| Baird | Maintained | Outperform | $302.00 from $290.00 | Jul 25, 2025 |
| Evercore ISI Group | Maintained | Outperform | $300.00 from $285.00 | Jul 25, 2025 |
Frequently asked questions
What is the price target for LH stock?
The average 12-month analyst price target for Labcorp (LH) is $333.57, with a high estimate of $360.00 and a low of $309.00, across 7 analysts.
Is LH a buy, sell, or hold?
Analysts covering Labcorp currently average a Buy rating: 15 buy, 5 hold and 1 sell, from 21 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for LH?
The average price target of $333.57 implies 0.06% upside from the last price of $333.39.
What is the latest analyst rating on LH?
On Aug 4, 2026, Piper Sandler maintained Labcorp at Neutral with a price target of $309.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.